AVE 16.7% 0.3¢ avecho biotechnology limited

the positive side if elixia launch ?fails?, page-4

  1. 5,774 Posts.
    lightbulb Created with Sketch. 318
    I guess there are a million variations possible Dougal.

    To me a launch is the first day. We are unlikely to make millions on the launch. lol

    To me its about outlets. This time they have organised widespread ways of getting to consumers. If in Australia they have 2000 outlets or equivilent and sell one bottle of product per week per outlet in 12 months we will get about $2-3 mill in revenue at my guesstimate.

    Worldwide 10000 outlets - we are pushing to $10-12 mil from tiny sales per outlet. This is my base/worst case scenario.

    If Cellucreme is good the sales will reflect onto the wider Elixia range if that connection is made clear.

    If cellucreme is not good we have a problem. But Esra is a fail early fail cheap CEO. It would not have got this far if not a ripper.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $194 65.5K

Buyers (Bids)

No. Vol. Price($)
50 88502619 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 60023414 20
View Market Depth
Last trade - 12.52pm 20/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.